Involvement of the tumour necrosis factor receptor system in glioblastoma cell death induced by palbociclib-heptamethine cyanine dye conjugate.
Autorzy:
Cooper E; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.; Department of Pharmacology, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.; Neurosurgery Research Unit, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand. Oyagawa CRM; Department of Pharmacology, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.; Neurosurgery Research Unit, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand. Johnson R; Department of Pharmacology, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.; Neurosurgery Research Unit, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand. ChoiPJ; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand. Foliaki JM; Department of Pharmacology, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.; Neurosurgery Research Unit, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand. Correia J; Neurosurgery Research Unit, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.; Department of Neurosurgery, Auckland City Hospital, Private Bag 92024, Auckland, 1142, New Zealand. Schweder P; Neurosurgery Research Unit, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.; Department of Neurosurgery, Auckland City Hospital, Private Bag 92024, Auckland, 1142, New Zealand. Heppner P; Neurosurgery Research Unit, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.; Department of Neurosurgery, Auckland City Hospital, Private Bag 92024, Auckland, 1142, New Zealand. Mee E; Neurosurgery Research Unit, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.; Department of Neurosurgery, Auckland City Hospital, Private Bag 92024, Auckland, 1142, New Zealand. Turner C; Neurosurgery Research Unit, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.; Department of Anatomical Pathology, Auckland City Hospital, 2 Park Road, LabPlus, Auckland, New Zealand. Faull R; Neurosurgery Research Unit, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand. Denny WA; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand. Dragunow M; Department of Pharmacology, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand. .; Neurosurgery Research Unit, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand. . Jose J; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand. . Park TI; Department of Pharmacology, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand. .; Neurosurgery Research Unit, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand. .
Elucidating the cellular uptake mechanisms of heptamethine cyanine dye analogues for their use as an anticancer drug-carrier molecule for the treatment of glioblastoma.
Autorzy:
Cooper E; Department of Pharmacology, University of Auckland, Auckland, New Zealand.; Neurosurgical Research Unit, The Centre for Brain Research, University of Auckland, Auckland, New Zealand.; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Auckland, New Zealand.; The Hugh Green Biobank, The Centre for Brain Research, University of Auckland, Auckland, New Zealand. ChoiPJ; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Auckland, New Zealand. Hwang K; Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea. Nam KM; Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea. Kim CY; Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea. Shaban T; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Auckland, New Zealand. Schweder P; Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea.; Department of Neurosurgery, Auckland City Hospital, Auckland, New Zealand. Mee E; Neurosurgical Research Unit, The Centre for Brain Research, University of Auckland, Auckland, New Zealand.; Department of Neurosurgery, Auckland City Hospital, Auckland, New Zealand. Correia J; Neurosurgical Research Unit, The Centre for Brain Research, University of Auckland, Auckland, New Zealand.; Department of Neurosurgery, Auckland City Hospital, Auckland, New Zealand. Turner C; Neurosurgical Research Unit, The Centre for Brain Research, University of Auckland, Auckland, New Zealand.; Department of Anatomical Pathology, Pathology and Laboratory Medicine, Auckland City Hospital, Auckland, New Zealand. Faull RLM; Neurosurgical Research Unit, The Centre for Brain Research, University of Auckland, Auckland, New Zealand. Denny WA; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Auckland, New Zealand. Noguchi K; Dojindo Laboratories Co., Ltd, Techno-Research Park, Kumamoto, Japan. Dragunow M; Department of Pharmacology, University of Auckland, Auckland, New Zealand.; Neurosurgical Research Unit, The Centre for Brain Research, University of Auckland, Auckland, New Zealand.; The Hugh Green Biobank, The Centre for Brain Research, University of Auckland, Auckland, New Zealand. Jose J; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Auckland, New Zealand. Park TI; Department of Pharmacology, University of Auckland, Auckland, New Zealand.; Neurosurgical Research Unit, The Centre for Brain Research, University of Auckland, Auckland, New Zealand.; The Hugh Green Biobank, The Centre for Brain Research, University of Auckland, Auckland, New Zealand.
Pokaż więcej
Źródło:
Chemical biology & drug design [Chem Biol Drug Des] 2023 Mar; Vol. 101 (3), pp. 696-716. Date of Electronic Publication: 2022 Nov 29.
Synthesis and Structure-Activity Relationships for the Anti-Mycobacterial Activity of 3-Phenyl- N -(Pyridin-2-ylmethyl)Pyrazolo[1,5- a ]Pyrimidin-7-Amines.
Autorzy:
Sutherland HS; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.; Maurice Wilkins Centre, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand. ChoiPJ; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.; Maurice Wilkins Centre, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand. Lu GL; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.; Maurice Wilkins Centre, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand. Giddens AC; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand. Tong AST; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand. Franzblau SG; Institute for Tuberculosis Research, College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, Chicago, IL 60612, USA. Cooper CB; Global Alliance for TB Drug Development, 40 Wall Street, New York, NY 10005, USA. Palmer BD; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.; Maurice Wilkins Centre, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand. Denny WA; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.; Maurice Wilkins Centre, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.
Conjugation of Palbociclib with MHI-148 Has an Increased Cytotoxic Effect for Breast Cancer Cells and an Altered Mechanism of Action.
Autorzy:
ChoiPJ; Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, University of Auckland, Auckland 1023, New Zealand.; Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland 1023, New Zealand. Tomek P; Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, University of Auckland, Auckland 1023, New Zealand. Tercel M; Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, University of Auckland, Auckland 1023, New Zealand.; Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland 1023, New Zealand. Reynisson J; School of Pharmacy and Bioengineering, Keele University, Hornbeam Building, Newcastle under Lyme, Staffordshire ST5 5BG, UK. Park TIH; Neurosurgical Research Unit & Department of Pharmacology, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland 1023, New Zealand. Cooper EA; Neurosurgical Research Unit & Department of Pharmacology, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland 1023, New Zealand. Denny WA; Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, University of Auckland, Auckland 1023, New Zealand.; Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland 1023, New Zealand. Jose J; Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, University of Auckland, Auckland 1023, New Zealand.; Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland 1023, New Zealand. Leung E; Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, University of Auckland, Auckland 1023, New Zealand.; Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland 1023, New Zealand.
Noninvasive ventilation: An important option in the management of hemidiaphragm paralysis.
Autorzy:
Carlson CS; Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan, USA. Brown SR; Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan, USA. Wilson MW; Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan, USA. ChoiPJ; Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Pokaż więcej
Źródło:
Journal of cardiac surgery [J Card Surg] 2021 Oct; Vol. 36 (10), pp. 3921-3923. Date of Electronic Publication: 2021 Jul 14.
Synthetic Studies to Help Elucidate the Metabolism of the Preclinical Candidate TBAJ-876-A Less Toxic and More Potent Analogue of Bedaquiline.
Autorzy:
ChoiPJ; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.; Maurice Wilkins Centre, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand. Conole D; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand. Sutherland HS; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand. Blaser A; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand. Tong AST; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand. Cooper CB; Global Alliance for TB Drug Development, 40 Wall St, New York, NY 10005, USA. Upton AM; Global Alliance for TB Drug Development, 40 Wall St, New York, NY 10005, USA. Palmer BD; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.; Maurice Wilkins Centre, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand. Denny WA; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.; Maurice Wilkins Centre, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.
Comparison of cadherin-17 expression between primary colorectal adenocarcinomas and their corresponding metastases: the possibility of a diagnostic marker for detecting the primary site of metastatic tumour.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
